In a shadow docket ruling late on Friday, April 21, the Supreme Court has decided to block a previous ruling from the U.S. Court of Appeals for the Fifth Circuit from taking effect, allowing the abortion pill mifepristone to remain on the market under current rules.
“While SCOTUS offered temporary relief, the fate of a medication approved by the FDA more than 20 years ago should have never been before the Supreme Court to begin with,” said Kirsten Moore of Expanding Medication Abortion Access Project.